Order Entry
United States
ContactUsLinkComponent
 
QuantiFluo™ Alkaline Phosphatase Assay Kit, BioAssay Systems
  75878-120
 :  
undefined
QuantiFluo™ Alkaline Phosphatase Assay Kit, BioAssay Systems
  75878-120
 :  QFAP-100
 :  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

 

  • Description:
    Alkaline Phosphatase Assay Kit
  • Size:
    100 assays
  • Method:
    FL360/450 nm
  • Sample:
    Serum, plasma, etc.
  • Processing Time:
    20 minutes
  • Cat. No.:
    75878-120
  • Supplier no.:
    QFAP-100

 

 

For quantitative fluorometric determination of alkaline phosphatase (ALP) activity.

  • Detection limit of 0.02 U/L
  • Simple "mix-and-measure" procedure allows reliable quantitation of ALP activity within 20 minutes
  • All reagents are compatible with high-throughput liquid handling instruments

Alkaline phosphatase (ALP) catalyzes the hydrolysis of phosphate esters in an alkaline environment, resulting in the formation of an organic radical and inorganic phosphate. In mammals, this enzyme is found mainly in the liver and bones. Marked increase in serum ALP levels, a disease known as hyperalkalinephosphatasemia, has been associated with malignant biliary obstruction, primary biliary cirrhosis, primary sclerosing cholangitis, hepatic lymphoma and sarcoidosis. Simple, direct and automation-ready. Procedures for measuring ALP activity in serum are becoming popular in Research and Drug Discovery. This improved method utilizes 4-methylumbelliferyl phosphate that is hydrolyzed by ALP into a highly fluorescent product 4-methylumbelliferone. The rate of the fluorescence increase is directly proportional to the enzyme activity.